Original news and analysis on international IP policy
A new policy brief from the Centre for International Governance Innovation, in Waterloo, Canada argues that Canada should pursue a weaker national patent regime. Acknowledging that Canada already has agreed to certain levels of protection through international treaties and trade agreements, Blit warns that future agreements that strengthen intellectual property protections would not benefit Canada.
In December, the United States Congress passed a bill with a monumental goal: engaging the private sector to work with each other, and with the government, to develop new treatments for cancer. The mechanics of cancer research, however, may require fundamental changes to our patent system if the initiative is to be successful. Intellectual Property Watch recently sat down with Jacob Sherkow, associate professor of law and affiliated faculty at the Innovation Center for Law and Technology at New York University Law School, to discuss challenges to overcome to get the Moonshot off the ground.
A letter made public only by a United States Freedom of Information Act (FOIA) request confirms that Michelle Lee remains the director of the US Patent and Trademark Office (USPTO), ending a mystery that has been curiously kept secret since President Trump took office over 50 days ago.
CAPE TOWN, South Africa - The five-metre tall 3D printer dwarfs four engineers in the renewable energy laboratory at the Nelson Mandela Metropolitan University, the biggest tertiary institution in the Eastern Cape, South Africa.
The Polish Ministry of Health has commenced consultations on an amendment to the act on reimbursements for drugs, foods intended for particular nutritional uses and medical devices. This bill envisions an entirely new system of refunds (full and partial), fixed maximum prices and fixed maximum margins for medical devices based partly on HTA, similar to the system currently in place for pharmaceuticals. The current wording leads one to believe that gradually all groups of medical devices could be introduced into this system. If the amendment is passed in the current shape, it has the potential to transform the medical devices market in Poland.
The United Nations Human Rights Council held a panel discussion yesterday to exchange views on good practices and key challenges relevant to access to medicines. The panel gave a large part of the discussion to the recent report of the United Nations Secretary General’s High-Level Panel on Access to Medicines, much to the chagrin of the European Union and the United States.
A recent workshop held on the doorstep of policymakers in the United States drew speakers from academic and activist circles to examine the mechanisms in US law which could help lead to lower prescription drug prices.
Danny Friedmann writes: When the holder of a medical patent finds herself on the patent cliff, staring into the abyss of a patentless and incomeless future, she will become very ingenious in applying for new uses, new pathways of delivery and new doses of the known substance. Painting a new layer of green over the patent that must give the impression of a new invention. It is the duty of the legislator to limit this kind of behavior if it stifles access to generic medicines. How can the interests of patent holders and patients be reconciled?
An event held at the World Trade Organization last week walked through key recommendations of the United Nations Secretary-General’s High-Level Panel on Access to Medicines, including strategies for moving some of them forward.
The European Patent Office published its 2016 annual report today, showing an “unprecedented level of patent filings,” and underlining the growing number of patent applications from China. The top technical fields for applications included medical technology, digital communication, and pharmaceuticals.
NAIROBI, Kenya -- A dispute between Kenyan researchers and the University of Manchester, United Kingdom, over ownership of a cancer discovered after successful clinical trials in Kenya finally seems headed to courts.
An "Access to Vaccines Index" was released today in the Netherlands that claims to "reveal the first landscape of vaccine company actions to improve immunisation coverage."